Skip to content

Prompt diagnosis and treatment by DOTS resulted in the control of prevalent tuberculosis in a high HIV prevalence Zimbabwean population

TB-related immune reaction to HIV therapy occurs 20 months after TB treatment first started - is this a record?

Scaling up laboratory capacity for the coming storm of XDR-TB, and why the HIV treating community must get involved now

Rifampicin levels strongly reduced in patients with TB and diabetes

Treating HIV and TB at the same time does not compromise outcome for either infection

Expanding beyond DOTS to stop TB

Family support just as good as directly observed therapy for TB treatment, Nepal study finds

CROI: Early vs delayed Trizivir in TB/HIV coinfected - no difference in rate of IRIS

ICAAC: TB patients with good CD4 cell counts can safely defer HIV treatment